Skip to content

Opening book details…

About this Biochemistry, Genetics and Molecular Biology article

Phase II study of a salvage regimen using cyclophosphamide, high‐dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma by Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoyo Kagami; Aya Oshiro; Akane Tsujimura; Kazuhito Yamamoto; Yasuo Morishima is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoyo Kagami; Aya Oshiro; Akane Tsujimura; Kazuhito Yamamoto; Yasuo Morishima
Publisher
John Wiley and Sons; Wiley (Blackwell Publishing); Wiley-Blackwell; Wiley; Research Square (ISSN 1347-9032)
Published
2007
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoyo Kagami; Aya Oshiro; Akane Tsujimura; Kazuhito Yamamoto; Yasuo Morishima

Browse all works by Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoyo Kagami; Aya Oshiro; Akane Tsujimura; Kazuhito Yamamoto; Yasuo Morishima